Clinical Studies

Clinical reports on the use of Vezotil®

Clinical Research Results

This section brings together clinical reports from veterinary institutions. The summaries are based on the attached PDFs; patient counts and outcomes are stated only where the source documents provide them.

8
clinical reports
8
institutions and research teams
PDF
original reports available to read

Participating Clinics and Research Results

Biocontrol Veterinary Oncology Research Center logo

Vezotil use at Biocontrol Veterinary Clinic

Biocontrol Veterinary Oncology Research Center

Clinical report on Vezotil® use during anesthesia in 28 dogs and cats

Principal investigator: E.A. Kornyushenkov
Period: 01.09.2023 - 12.10.2023
Patients: 28 dogs and cats

Key Findings:

  • Vezotil® was used as part of an anesthetic protocol
  • Hypotension was reported in five cats and two dogs
  • One cat required vasopressor support
Dobry Doctor Veterinary Clinic, Vladimir logo

Study at Dobry Doctor Veterinary Clinic

Dobry Doctor Veterinary Clinic, Vladimir

Clinical report on Vezotil® use in cats undergoing surgical procedures

Principal investigator: E.E. Chukhlov
Period: 07.08.2023 – 30.09.2023
Patients: 24 cats

Key Findings:

  • Investigators described the course of anesthesia as smooth
  • Time to head lift was 10–50 minutes
  • No new adverse events were reported
Four Paws Veterinary Clinic logo

Study at Four Paws Veterinary Clinic

Four Paws Veterinary Clinic

Report on Vezotil® use at a specialized veterinary clinic in Moscow

Principal investigator: O.D. Bobunova
Period: 01.08.2023 – 30.09.2023
Patients: Dogs and cats; number not stated

Key Findings:

  • The report describes use with dexmedetomidine
  • The investigator noted smooth recovery
  • No adverse effects were reported in these observations
VetProfAlliance Veterinary Clinics logo

Study at VetProfAlliance Veterinary Clinics

VetProfAlliance Veterinary Clinics

Clinical report from two veterinary centers in Moscow and Chekhov

Principal investigator: S.A. Yagnikov
Period: 24.08.2023 – 04.09.2023
Patients: 14 animals: 8 dogs and 6 cats

Key Findings:

  • The report describes 14 patients at two centers
  • Time to head lift was 10–30 minutes
  • No new adverse events were reported
Pantera Veterinary Clinic logo

Study at Pantera Veterinary Clinic

Pantera Veterinary Clinic

Clinical report on Vezotil® use in the Moscow Region

Principal investigator: N.V. Larosa
Period: 01.08.2023 – 30.09.2023
Patients: 76 animals: 45 dogs and 31 cats

Key Findings:

  • The report describes 76 dogs and cats
  • Time to head lift was 10–20 minutes
  • No complications attributed to Vezotil® were reported
Best Veterinary Clinic Network logo

Study at the Best Veterinary Clinic Network

Best Veterinary Clinic Network

Clinical report on Vezotil® use in Novosibirsk

Principal investigator: T.S. Ruzanova
Period: 11.06.2024 – 24.06.2024
Patients: Dogs and cats; number not stated

Key Findings:

  • The report notes smooth sedation
  • Dose-dependent hypersalivation and postoperative nausea were reported
  • Apnea may occur when combined with propofol
VetLife Veterinary Clinic logo

Study at VetLife Veterinary Clinic

VetLife Veterinary Clinic

Report on Vezotil® use in a multidisciplinary veterinary practice

Principal investigator: S.G. Atanasova
Period: 01.10.2023 – 01.12.2023
Patients: 24 patients: 14 dogs and 10 cats

Key Findings:

  • The report describes 24 patients
  • Vezotil® was used in combined protocols
  • Investigators report that procedures were completed without complications
Moscow Zoo logo

Study at Moscow Zoo

Moscow Zoo

Clinical report on remote immobilization of animals from three species

Principal investigator: D.N. Egorov
Period: From 01.05.2024; end date not stated in the report
Patients: 9 animals: 5 markhor goats, 3 zebu, and 1 wolverine

Key Findings:

  • Three zebu, five markhor goats, and one wolverine were described
  • Vezotil® was used with medetomidine
  • No new adverse effects were described in the report

How to read the clinical reports

Different patient groups

The reports cover different clinics, animal species, and procedures.

Patient counts are shown only when stated in the original PDF.

In some reports, Vezotil® was used alongside other anesthetic agents.

Limits of the conclusions

These reports do not establish a single success rate or adverse-event frequency for all patients.

Open each full PDF to review the findings and conditions of use.